Home/Filings/4/0001193125-25-284996
4//SEC Filing

Ali Faraz 4

Accession 0001193125-25-284996

CIK 0001858848other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 8:33 PM ET

Size

5.0 KB

Accession

0001193125-25-284996

Insider Transaction Report

Form 4
Period: 2025-11-17
Ali Faraz
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-11-17$1.33/sh3,126$4,158299,666 total
Footnotes (2)
  • [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
  • [F2]Includes 211,275 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Documents

1 file

Issuer

Tenaya Therapeutics, Inc.

CIK 0001858848

Entity typeother

Related Parties

1
  • filerCIK 0001667937

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:33 PM ET
Size
5.0 KB